People are increasingly booking themselves appointments with backstreet clinics whose staff lack medical training.

By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...

Akero reported Monday strong results showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused ...

To put it simply, it means options. The expansion of this category is huge for anyone struggling with confidence due to scarring and for those looking for more sophisticated solutions to daily care.